Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)
Clinical trial NCT05281003 · RECRUITING
Trial details
- NCT number
- NCT05281003
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-20
- Primary completion
- 2023-09-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.